Enzalutamide is a nonsteroidal antiandrogen medication indicated for the treatment of prostate cancer. Laboratories require high-quality reference standards for this drug to ensure accurate analytical… Read more








































![Chemical structure of 4-[[2-[[4-Cyano-3-(trifluoromethyl)phenyl]amino]-1,1-dimethyl-2-oxoethyl]amino]-2-fluoro-N-methyl-benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1289942-55-7-4-2-4-Cyano-3-trifluoromethylphenylamino-11-dimethyl-2-oxoethylamino-2-fluoro-N-methyl-benzamide.png&w=3840&q=75)









Enzalutamide is a nonsteroidal antiandrogen medication indicated for the treatment of prostate cancer. Laboratories require high-quality reference standards for this drug to ensure accurate analytical results. The provided catalogue encompasses the API itself, along with a comprehensive range of pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. These materials are essential for conducting rigorous impurity profiling and method validation, helping researchers identify and quantify potential byproducts formed through pathways such as hydrolysis and oxidation. Stable isotope labelled standards, such as deuterium-labelled variants, are critical for use as internal standards in mass spectrometry-based assays, ensuring precision during complex quality control testing. By utilizing these characterized reference materials, pharmaceutical laboratories can maintain compliance with industry guidelines, support structural characterization studies, and confirm the stability and safety of their drug products throughout the analytical lifecycle.